Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke for Omicron Rehabilitation
NCT05625022Phase 4Unknown
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Nov 2022
- Primary completion
- Jun 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Lianhua Qingke in coronavirus disease 2019 (COVID-19), sponsored by Qilu Hospital of Shandong University. Status: unknown.
02
Drugs
Lianhua Qingke
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05625022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05625022.